The Dow Jones fell by more than 2% in what turned out to be its worst one-day sell-off since the beginning of the year. Two companies that would be great options in case of another market downturn are AbbVie (NYSE: ABBV) and Netflix (NASDAQ: NFLX). Pharma giant AbbVie will likely start facing competition from biosimilars in the U.S. for Humira, its best-selling drug, in 2023.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting